If they were actually considering a Nasdaq listing that would be a scary idea. That would basically be telling us they need more access to capital and want exposure to the US market. Why would you want exposure to the US market when you have partnerships with the majors....
I really hope this isn't the case as dual listings have all sorts of costs and new disclosure requirements on a US GAAP basis.
- Forums
- ASX - By Stock
- VLA
- 2 biotech shares with explosive potential
2 biotech shares with explosive potential, page-5
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)